Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.

Autor: Lin, Thomas S.1 (AUTHOR), Naumovski, Louie2 (AUTHOR), Lecane, Philip S.2 (AUTHOR), Lucas, Margaret S.1 (AUTHOR), Moran, Mollie E.1 (AUTHOR), Cheney, Carolyn1 (AUTHOR), Lucas, David M.1 (AUTHOR), Phan, See-Chun2 (AUTHOR), Miller, Richard A.2 (AUTHOR), Byrd, John C.1 (AUTHOR) john.byrd@osumc.edu
Zdroj: Leukemia & Lymphoma. Dec2009, Vol. 50 Issue 12, p1977-1982. 6p. 3 Charts, 1 Graph.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje